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Resumen.
Introduction.
Most genetic studies in colorectal carcinomas (CRC) have focused on those abnormalities that are 
acquired by primary tumours, particularly in the transition from adenoma to carcinoma, while few 
studies have compared the genetic abnormalities of primary vs. paired metastatic samples. Material 
and Methods:  In this study we used high-density 500K SNP arrays to map the overall genetic 
changes present in liver metastases (n=20) from untreated CRC patients studied at diagnosis versus 
their paired primary tumours (n=20). Results: Overall, metastatic tumours systematically contained 
those genetic abnormalities observed in the primary tumour sample from the same subject. 
However, liver metastases from most cases (n=8/20) showed acquisition of genetic aberrations that 
were not found in their paired primary tumors. These new metastatic aberrations mainly consisted 
of 1) an increased frequency of genetic lesions of chromosomes that have been associated with 
metastatic CRC (1p, 7p, 8q, 13q, 17p, 18q, 20q) and, more interestingly, 2) acquisition of new 
chromosomal abnormalities (e.g. losses of chromosomes 4 and 10q and gains of chromosomes 5p 
and 6p). Conclusions: These genetic changes acquired by metastatic tumours may be associated 
with either the metastatic process and/or adaption of metastatic cells to the liver microenvironment. 
Further studies in larger series of patients are necessary to dissect the specific role of each of the 
altered genes and chromosomal regions in the metastatic spread of CRC tumours.
